A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma

収録刊行物

• Cancer Chemother Pharmacol

  Cancer Chemother Pharmacol 44 307-311, 1999